Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Cti Biopharma Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 102.0K | 0 | −102.0K (−100.0%) |
| Value | $474.2K | $0 | −$474.2K (−100.0%) |
New holders (0)
Institutions that held Cti Biopharma Corp at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (2)
Institutions that held Cti Biopharma Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| UBS Asset Management Americas Inc | 92,700 | $389.3K |
| Legal & General Group Plc | 9,340 | $84.9K |